Matches in Wikidata for { <http://www.wikidata.org/entity/Q90283202> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q90283202 description "artículu científicu espublizáu n'avientu de 2018" @default.
- Q90283202 description "im Dezember 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q90283202 description "scientific article published on 01 December 2018" @default.
- Q90283202 description "wetenschappelijk artikel" @default.
- Q90283202 description "наукова стаття, опублікована в грудні 2018" @default.
- Q90283202 name "Safety of pembrolizumab while commencing treatment for hepatitis C with Harvoni (ledipasvir and sofosbuvir)" @default.
- Q90283202 name "Safety of pembrolizumab while commencing treatment for hepatitis C with Harvoni (ledipasvir and sofosbuvir)" @default.
- Q90283202 type Item @default.
- Q90283202 label "Safety of pembrolizumab while commencing treatment for hepatitis C with Harvoni (ledipasvir and sofosbuvir)" @default.
- Q90283202 label "Safety of pembrolizumab while commencing treatment for hepatitis C with Harvoni (ledipasvir and sofosbuvir)" @default.
- Q90283202 prefLabel "Safety of pembrolizumab while commencing treatment for hepatitis C with Harvoni (ledipasvir and sofosbuvir)" @default.
- Q90283202 prefLabel "Safety of pembrolizumab while commencing treatment for hepatitis C with Harvoni (ledipasvir and sofosbuvir)" @default.
- Q90283202 P1433 Q90283202-C6995195-CC6B-445A-8B61-944297283FF6 @default.
- Q90283202 P1476 Q90283202-0543F737-0B3F-4F75-B67F-7E51EEE28A23 @default.
- Q90283202 P2093 Q90283202-17F63E85-5FB3-4F0A-9F49-D5B63249DEC3 @default.
- Q90283202 P2093 Q90283202-62F77CC2-E4D4-4F90-948D-03C5FD458243 @default.
- Q90283202 P304 Q90283202-690E19DF-29F1-48AC-B027-F0FDE23640CD @default.
- Q90283202 P31 Q90283202-2D6E9E96-B052-4CEA-B2FB-0930CDF61731 @default.
- Q90283202 P356 Q90283202-A71D66D7-E1BD-45B3-97EF-0EF68DFA8C74 @default.
- Q90283202 P433 Q90283202-C3D71FC1-C204-405A-8F37-E8267407C2C0 @default.
- Q90283202 P478 Q90283202-FC486F95-5D13-45C6-96A7-F2A24540E42C @default.
- Q90283202 P50 Q90283202-5D525A76-D924-4EA6-BA64-50413F7D25D9 @default.
- Q90283202 P577 Q90283202-722C9FFF-97BD-4518-9F62-281504E1B285 @default.
- Q90283202 P698 Q90283202-FDC22403-BF36-4A0E-A11D-6AA72D2BB775 @default.
- Q90283202 P921 Q90283202-243A7743-3EE1-457D-B72B-94D90D0A0480 @default.
- Q90283202 P921 Q90283202-2E17CE2B-7975-450A-9A33-F3AF0C78880A @default.
- Q90283202 P921 Q90283202-889D5700-B9EF-4B80-B44C-AB3D8005F184 @default.
- Q90283202 P356 IMJ.14131 @default.
- Q90283202 P698 30517998 @default.
- Q90283202 P1433 Q15749165 @default.
- Q90283202 P1476 "Safety of pembrolizumab while commencing treatment for hepatitis C with Harvoni (ledipasvir and sofosbuvir)" @default.
- Q90283202 P2093 "Lalitha L Menon" @default.
- Q90283202 P2093 "Muhammad A Khattak" @default.
- Q90283202 P304 "1542-1543" @default.
- Q90283202 P31 Q13442814 @default.
- Q90283202 P356 "10.1111/IMJ.14131" @default.
- Q90283202 P433 "12" @default.
- Q90283202 P478 "48" @default.
- Q90283202 P50 Q90283198 @default.
- Q90283202 P577 "2018-12-01T00:00:00Z" @default.
- Q90283202 P698 "30517998" @default.
- Q90283202 P921 Q13896859 @default.
- Q90283202 P921 Q15409409 @default.
- Q90283202 P921 Q2502747 @default.